Pieris Pharmaceuticals Inc (PIRS)
16.64
+0.71
(+4.44%)
USD |
NASDAQ |
Nov 22, 16:00
16.64
0.00 (0.00%)
After-Hours: 16:27
Pieris Pharmaceuticals Total Liabilities (Quarterly): 4.254M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.254M |
| June 30, 2024 | 6.346M |
| March 31, 2024 | 7.533M |
| December 31, 2023 | 11.92M |
| September 30, 2023 | 28.87M |
| June 30, 2023 | 47.05M |
| March 31, 2023 | 66.80M |
| December 31, 2022 | 67.56M |
| September 30, 2022 | 63.40M |
| June 30, 2022 | 69.94M |
| March 31, 2022 | 83.66M |
| December 31, 2021 | 102.80M |
| September 30, 2021 | 110.33M |
| June 30, 2021 | 108.31M |
| March 31, 2021 | 77.55M |
| December 31, 2020 | 73.98M |
| September 30, 2020 | 72.03M |
| June 30, 2020 | 71.11M |
| March 31, 2020 | 73.97M |
| December 31, 2019 | 89.74M |
| September 30, 2019 | 96.11M |
| June 30, 2019 | 111.36M |
| Date | Value |
|---|---|
| March 31, 2019 | 100.89M |
| December 31, 2018 | 101.41M |
| September 30, 2018 | 101.40M |
| June 30, 2018 | 106.71M |
| March 31, 2018 | 122.55M |
| December 31, 2017 | 92.35M |
| September 30, 2017 | 94.30M |
| June 30, 2017 | 96.62M |
| March 31, 2017 | 43.84M |
| December 31, 2016 | 9.836M |
| September 30, 2016 | 12.23M |
| June 30, 2016 | 9.163M |
| March 31, 2016 | 10.03M |
| December 31, 2015 | 2.822M |
| September 30, 2015 | 2.550M |
| June 30, 2015 | 3.330M |
| March 31, 2015 | 2.547M |
| September 30, 2014 | 0.0011M |
| June 30, 2014 | 0.0011M |
| March 31, 2014 | 0.005M |
| December 31, 2013 | 0.0033M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.254M
Minimum
Sep 2024
110.33M
Maximum
Sep 2021
61.86M
Average
70.53M
Median
Total Liabilities (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 113.69M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 20.52M |
| Shareholders Equity (Quarterly) | 16.27M |